Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Madeira, Maria H ^a,b   Ortin Martinez, Arturo ^c   Nadal Nícolas, Francisco ^c   Ambrósio, António F ^a,b,d   Vidal Sanz, Manuel ^c   Agudo Barriuso, Marta ^c   Santiago, Ana Raquel ^a,b,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF MURCIA   (Spain)

^d ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ANIMAL; CENTRAL NERVOUS SYSTEM; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GLAUCOMA; HUMAN; INFLAMMATION; INJURIES; INTRAOCULAR PRESSURE; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; RAT; RETINA; RETINA GANGLION CELL; SPRAGUE DAWLEY RAT;

ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; GLAUCOMA; HUMANS; INFLAMMATION; INTRAOCULAR PRESSURE; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS;

EID: 84976443381     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27532     Document Type: Article

References (65)

1. Casson, R. J., Chidlow, G., Wood, J. P., Crowston, J. G. & Goldberg, I. Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol 40, 341-349, doi: 10.1111/j.1442-9071.2012.02773.x (2012).
2. Caprioli, J. Glaucoma: a disease of early cellular senescence. Invest Ophthalmol Vis Sci 54, ORSF60-67, doi: 10.1167/iovs.13-12716 (2013).
3. Cordeiro, M. F. & Levin, L. A. Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol 152, 715-716, doi: 10.1016/j. ajo.2011.06.015 (2011).
4. Yoneda, S. et al. Interleukin-1beta mediates ischemic injury in the rat retina. Exp Eye Res 73, 661-667, doi: 10.1006/exer.2001.1072 (2001).
5. Cho, K. J., Kim, J. H., Park, H. Y. & Park, C. K. Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion. Brain Res 1403, 67-77, doi: 10.1016/j.brainres.2011.06.005 (2011).
6. Tezel, G., Li, L. Y., Patil, R. V. & Wax, M. B. TNF-Alpha and TNF-Alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 42, 1787-1794 (2001).
7. Yuan, L. & Neufeld, A. H. Tumor necrosis factor-Alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32, 42-50, doi: 10.1002/1098-1136(200010)32:1 3.0.CO;2-3 (2000).
8. Naskar, R., Wissing, M. & Thanos, S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci 43, 2962-2968 (2002).
9. Bosco, A., Steele, M. R. & Vetter, M. L. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 519, 599-620, doi: 10.1002/cne.22516 (2011).
10. Wang, J. W., Chen, S. D., Zhang, X. L. & Jonas, J. B. Retinal Microglia in Glaucoma. J Glaucoma Epub 2015 Feb 23, doi: 10.1097/IJG.0000000000000200 (2015).
11. Bosco, A. et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 49, 1437-1446, doi: 10.1167/iovs.07-1337 (2008).
12. Roh, M. et al. Etanercept, a widely used inhibitor of tumor necrosis factor-Alpha (TNF-Alpha), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One 7, e40065, doi: 10.1371/journal.pone.0040065 (2012).
13. Wang, K., Peng, B. & Lin, B. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model. Glia 62, 1943-1954, doi: 10.1002/glia.22715 (2014).
14. Santiago, A. R. et al. Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases. Mediators Inflamm 2014, 465694, doi: 10.1155/2014/465694 (2014).
15. Madeira, M. H. et al. Adenosine A2R blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure. J Neuroinflammation 12, 115, doi: 10.1186/s12974-015-0333-5 (2015).
16. Madeira, M. H. et al. Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury. Transl Res 169, 112-128, doi: 10.1016/j. trsl.2015.11.005 (2016).
17. Fredholm, B. B., Chen, J. F., Cunha, R. A., Svenningsson, P. & Vaugeois, J. M. Adenosine and brain function. Int Rev Neurobiol 63, 191-270, doi: 10.1016/S0074-7742(05)63007-3 (2005).
18. Matos, M. et al. Astrocytic adenosine A2A receptors control the amyloid-beta peptide-induced decrease of glutamate uptake. J Alzheimers Dis 31, 555-567, doi: 10.3233/JAD-2012-120469 (2012).
19. Espinosa, J. et al. Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. J Alzheimers Dis 34, 509-518, doi: 10.3233/JAD-111982 (2013).
20. Prediger, R. D. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis 20 Suppl 1, S205-220, doi: 10.3233/JAD-2010-091459 (2010).
21. Cunha, R. A. & Agostinho, P. M. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 20 Suppl 1, S95-116, doi: 10.3233/JAD-2010-1408 (2010).
22. Lee, K. W. et al. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease. Neurotherapeutics 10, 143-153, doi: 10.1007/s13311-012-0165-2 (2013).
23. Brothers, H. M., Marchalant, Y. & Wenk, G. L. Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci Lett 480, 97-100, doi: 10.1016/j.neulet.2010.06.013 (2010).
24. Salinas-Navarro, M. et al. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp Eye Res 90, 168-183, doi: 10.1016/j.exer.2009.10.003 (2010).
25. Agudo-Barriuso, M., Villegas-Perez, M. P., de Imperial, J. M. & Vidal-Sanz, M. Anatomical and functional damage in experimental glaucoma. Curr Opin Pharmacol 13, 5-11, doi: 10.1016/j.coph.2012.09.006 (2013).
26. Vidal-Sanz, M. et al. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog Retin Eye Res 31, 1-27, doi: 10.1016/j.preteyeres.2011.08.001 (2012).
27. Ortin-Martinez, A. et al. Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors. Exp Eye Res 132, 17-33, doi: 10.1016/j.exer.2015.01.006 (2015).
28. Avisar, R., Avisar, E. & Weinberger, D. Effect of coffee consumption on intraocular pressure. Ann Pharmacother 36, 992-995 (2002).
29. Rivera-Oliver, M. & Diaz-Rios, M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci 101, 1-9, doi: 10.1016/j.lfs.2014.01.083 (2014).
30. Madeira, M. H., Boia, R., Santos, P. F., Ambrosio, A. F. & Santiago, A. R. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm 2015, 673090, doi: 10.1155/2015/673090 (2015).
31. Karlstetter, M. et al. Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res 45, 30-57, doi: 10.1016/j. preteyeres.2014.11.004 (2015).
32. Scholz, R. et al. Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration. J Neuroinflammation 12, 201, doi: 10.1186/s12974-015-0422-5 (2015).
33. Karlstetter, M. et al. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis. J Neuroinflammation 11, 3, doi: 10.1186/1742-2094-11-3 (2014).
34. Wang, M. et al. Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina. J Neurosci 34, 3793-3806, doi: 10.1523/JNEUROSCI.3153-13.2014 (2014).
35. Gallego, B. I. et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation 9, 92, doi: 10.1186/1742-2094-9-92 (2012).
36. Rojas, B. et al. Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers. J Neuroinflammation 11, 133, doi: 10.1186/1742-2094-11-133 (2014).
37. Mabuchi, F., Aihara, M., Mackey, M. R., Lindsey, J. D. & Weinreb, R. N. Optic nerve damage in experimental mouse ocular hypertension. Invest Ophthalmol Vis Sci 44, 4321-4330 (2003).
38. Salinas-Navarro, M. et al. Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice. Mol Vis 15, 2578-2598 (2009).
39. Kalda, A., Yu, L., Oztas, E. & Chen, J. F. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J Neurol Sci 248, 9-15, doi: 10.1016/j.jns.2006.05.003 (2006).
40. Nadal-Nicolas, F. M. et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50, 3860-3868, doi: 10.1167/iovs.08-3267 (2009).
41. Rebola, N. et al. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. J Neurochem 117, 100-111, doi: 10.1111/j.1471-4159.2011.07178.x (2011).
42. Yu, L. et al. Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann Neurol 63, 338-346, doi: 10.1002/ana.21313 (2008).
43. Boia, R., Ambrosio, A. F. & Santiago, A. R. Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases. Ophthalmic Res 55, 212-218, doi: 10.1159/000443893 (2016).
44. Chandra, P., Gaur, A. & Varma, S. Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma. Clin Ophthalmol 5, 1623-1629, doi: 10.2147/OPTH.S25291 (2011).
45. Aihara, M., Lindsey, J. D. & Weinreb, R. N. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci 44, 4314-4320 (2003).
46. Yuan, L. & Neufeld, A. H. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64, 523-532 (2001).
47. Tezel, G. & Wax, M. B. Increased production of tumor necrosis factor-Alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 20, 8693-8700 (2000).
48. Chidlow, G., Wood, J. P., Ebneter, A. & Casson, R. J. Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells. Neurobiol Dis 48, 568-581, doi: 10.1016/j. nbd.2012.07.026 (2012).
49. Bosco, A. et al. Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One 7, e43602, doi: 10.1371/journal.pone.0043602 (2012).
50. Shin, E. S., Huang, Q., Gurel, Z., Sorenson, C. M. & Sheibani, N. High glucose alters retinal astrocytes phenotype through increased production of inflammatory cytokines and oxidative stress. PLoS One 9, e103148, doi: 10.1371/journal.pone.0103148 (2014).
51. Matos, M. et al. Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia 60, 702-716, doi: 10.1002/glia.22290 (2012).
52. Fahy, E. T., Chrysostomou, V. & Crowston, J. G. Impaired Axonal Transport and Glaucoma. Curr Eye Res. 1-11, doi: 10.3109/02713683.2015.1037924 (2015).
53. Chidlow, G., Ebneter, A., Wood, J. P. & Casson, R. J. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol 121, 737-751, doi: 10.1007/s00401-011-0807-1 (2011).
54. Joos, K. M., Li, C. & Sappington, R. M. Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure. Invest Ophthalmol Vis Sci 51, 6431-6440, doi: 10.1167/iovs.10-5212 (2010).
55. Munemasa, Y. & Kitaoka, Y. Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection. Front Cell Neurosci 6, 60, doi: 10.3389/fncel.2012.00060 (2012).
56. Ebneter, A., Casson, R. J., Wood, J. P. & Chidlow, G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci 51, 6448-6460, doi: 10.1167/iovs.10-5284 (2010).
57. de Hoz, R. et al. Rod-like microglia are restricted to eyes with laser-induced ocular hypertension but absent from the microglial changes in the contralateral untreated eye. PLoS One 8, e83733, doi: 10.1371/journal.pone.0083733 (2013).
58. Ramirez, A. I. et al. Quantification of the effect of different levels of IOP in the astroglia of the rat retina ipsilateral and contralateral to experimental glaucoma. Invest Ophthalmol Vis Sci 51, 5690-5696, doi: 10.1167/iovs.10-5248 (2010).
59. Goncalves, N., Simoes, A. T., Cunha, R. A. & de Almeida, L. P. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease. Ann Neurol 73, 655-666, doi: 10.1002/ana.23866 (2013).
60. Sappington, R. M., Carlson, B. J., Crish, S. D. & Calkins, D. J. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci 51, 207-216, doi: 10.1167/iovs.09-3947 (2010).
61. Nadal-Nicolas, F. M., Salinas-Navarro, M., Vidal-Sanz, M. & Agudo-Barriuso, M. Two methods to trace retinal ganglion cells with fluorogold: from the intact optic nerve or by stereotactic injection into the optic tract. Exp Eye Res 131, 12-19, doi: 10.1016/j. exer.2014.12.005 (2015).
62. Salinas-Navarro, M. et al. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vision Res 49, 115-126, doi: 10.1016/j.visres.2008.09.029 (2009).
63. Santiago, A. R. et al. Diabetes changes the levels of ionotropic glutamate receptors in the rat retina. Mol Vis 15, 1620-1630 (2009).
64. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 25, 402-408, doi: 10.1006/meth.2001.1262 (2001).
65. Andersen, C. L., Jensen, J. L. & Orntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64, 5245-5250, doi: 10.1158/0008-5472.CAN-04-0496 (2004).